Table A1.
Frequency Distribution of Selected Characteristics of Study Subjects in UCSF and Sweden Replication Groups
| Variable | UCSF (N = 352) |
Sweden (N = 191) |
||||
|---|---|---|---|---|---|---|
| No. of Patients | No. of Deaths | MST (months) | No. of Patients | No. of Deaths | MST (months) | |
| All | 352 | 300 | 16.3 | 191 | 165 | 13.9 |
| Age | ||||||
| ≤ 50 | 120 | 92 | 20.4 | 50 | 40 | 15.6 |
| > 50 | 232 | 208 | 14.4 | 141 | 125 | 13.2 |
| Sex | ||||||
| Male | 229 | 194 | 16.2 | 117 | 104 | 12.7 |
| Female | 123 | 106 | 18.2 | 74 | 61 | 21.8 |
| Radiation therapy | ||||||
| No | 8 | 8 | 6.7 | NA | ||
| Yes | 344 | 292 | 17.1 | |||
| Chemotherapy | ||||||
| No chemotherapy | 24 | 22 | 9.8 | NA | ||
| Temodar given | 291 | 245 | 17.8 | |||
| Other chemotherapy | 36 | 32 | 15.9 | |||
| Extent of surgical resection | ||||||
| Biopsy only | 29 | 26 | 11.6 | NA | ||
| Resection | 323 | 274 | 17.1 | |||
Abbreviations: UCSF, University of California San Francisco; MST, median survival time; NA, not available.